Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Choline phosphate-based bioactive hydrogel for sustained release of exosomes from adipose-derived stem cells to enhance diabetic wound healing.

He X., Wang Y., Yang D., Liu J., Kang X., Sun T.

Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, Immune Modulation, published in Colloids Surf B Biointerfaces (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Colloids Surf B Biointerfaces (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41846095
DOI
10.1016/j.colsurfb.2026.115618

Abstract (original English)

Diabetic non-healing wounds remain a formidable clinical challenge, often leading to severe complications and high morbidity. Their impaired healing capacity is largely attributed to insufficient neovascularization, chronic inflammation, reduced collagen deposition, and a high risk of bacterial infection. Adipose-derived mesenchymal stem cell exosomes (AE) have shown promise in wound repair by promoting immunomodulation and neovascularization. However, traditional physical loading methods frequently result in exosome loss or inactivation, limiting their therapeutic efficacy. To overcome these limitations, we develop a Gelatin Methacryloyl-methacrylated choline phosphate bioactive hydrogel via free radical polymerization. This bioactive hydrogel incorporates AE through specific "choline phosphate-phosphatidylcholine" (CP-PC) conjugation, ensuring their stability and sustained release, while antibacterial metal-organic frameworks, activated by blue light and enhancing curcumin bioavailability, are physically blended into the hydrogel matrix. The bioactive hydrogel accelerates wound healing by suppressing bacterial growth and reducing inflammation during the initial phase, enhancing endothelial cell migration and tubule formation in the proliferative phase. In vitro and in vivo evaluations confirm its potent antibacterial, anti-inflammatory, and antioxidant activities, significant

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Wound HealingAnimalsExosomesHydrogelsAnti-Bacterial AgentsMesenchymal Stem CellsPhosphorylcholineAdipose TissueHumansCell Proliferation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research